Tomoko Dai
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High expression of eukaryotic elongation factor 1-alpha-2 in lung adenocarcinoma is associated with poor prognosis.
Journal: Pathology international
Published: September 04, 2023
In-depth proteomics reveals the characteristic developmental profiles of early lung adenocarcinoma with epidermal growth factor receptor mutation.
Journal: Cancer medicine
Published: August 30, 2022
DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma.
Journal: Oncotarget
Published: November 29, 2018
Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: March 08, 2018
The prognostic significance of N-myc downregulated gene 1 in lung adenocarcinoma.
Journal: Pathology international
Published: November 30, 2017
Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 28, 2016
miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma.
Journal: Cancer science
Published: September 14, 2016
Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans.
Journal: Oncotarget
Published: November 28, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026